Kristin P. Bibee, Ph.D. - Publications
Affiliations: | 2013 | Biology & Biomedical Sciences (Molecular Cell Biology) | Washington University, Saint Louis, St. Louis, MO |
Area:
Cell Biology, Nanotechnology, Medicine and SurgeryYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Bibee KP, Cheng YJ, Ching JK, Marsh JN, Li AJ, Keeling RM, Connolly AM, Golumbek PT, Myerson JW, Hu G, Chen J, Shannon WD, Lanza GM, Weihl CC, Wickline SA. Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 2047-61. PMID 24500923 DOI: 10.1096/Fj.13-237388 | 0.516 | |||
2011 | Zhang H, Zhang L, Myerson J, Bibee K, Scott M, Allen J, Sicard G, Lanza G, Wickline S. Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents. Plos One. 6: e26385. PMID 22028868 DOI: 10.1371/Journal.Pone.0026385 | 0.557 | |||
2011 | Sim H, Bibee K, Wickline S, Sept D. Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy. Cancer Research. 71: 686-92. PMID 21123454 DOI: 10.1158/0008-5472.Can-10-2666 | 0.421 | |||
2010 | Zhang L, Zhang H, Bibee K, Allen J, Chen J, Lanza GM, Wickline SA. Quantitative molecular imaging of atherosclerotic endothelial dysfunction with perfluorocarbon (19F) nanoparticle magnetic resonance imaging and spectroscopy Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-P120 | 0.5 | |||
2010 | Bibee K, Li A, Wickline S. Abstract P2-19-02: mTOR Pathway Inhibitor Nanoparticles Beneficially Modulate Autophagy in Triple Negative Breast Cancer Cells Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P2-19-02 | 0.515 | |||
Show low-probability matches. |